Surgical endoscopy · 2026
Clinical outcomes of endoscopic balloon dilatation for postoperative anastomotic stricture after distal gastrectomy.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Seo Jun-Young, Na Hee Kyong, Ko Chang Seok, Ahn Ji Yong, Lee Jeong Hoon, Jung Kee Wook, Kim Do Hoon, Choi Kee Don, Song Ho June, Yook Jeong Hwan, Kim Beom Su, Yoo Moon-Won, Lee Gin Hyug, Jung Hwoon-Yong
Аннотация
BACKGROUND: Postoperative anastomotic luminal obstruction is a rare but clinically significant complication after distal gastrectomy. Endoscopic balloon dilatation (EBD) is a minimally invasive treatment; however, some patients require additional interventions. This study aimed to evaluate the clinical outcomes of EBD for postoperative anastomotic luminal narrowing and to identify predictors associated with treatment failure.
METHODS: We retrospectively reviewed 56 patients who developed anastomotic strictures after distal gastrectomy, and treated with EBD between January 2010 and December 2022 at Asan Medical Center, Seoul, Korea. Clinical data, including patient characteristics, surgical factors, and endoscopic findings, were analyzed. Patients were classified into an EBD-only group and an additional-intervention group (stent insertion or surgery). Univariate and multivariable logistic regression analyses were performed to identify predictors of EBD refractoriness.
RESULTS: Of the 56 patients, 45 (80.3%) achieved symptom improvement with EBD alone, whereas 11 (19.6%) required additional interventions. Diabetes mellitus and failure of scope passage were more frequent in patients who required additional interventions compared with those treated with EBD alone. Multivariable analysis indicated that only failure of scope passage remained an independent predictor (odds ratio, 16.81; 95% confidence interval, 1.61-411.44; p = 0.030). There was one procedure-related complication, aspiration pneumonia, which improved with conservative treatment.
CONCLUSIONS: EBD is an effective and safe first-line treatment for anastomotic strictures after distal gastrectomy. Failure of scope passage through the anastomosis is a simple yet reliable predictor of EBD refractoriness.
METHODS: We retrospectively reviewed 56 patients who developed anastomotic strictures after distal gastrectomy, and treated with EBD between January 2010 and December 2022 at Asan Medical Center, Seoul, Korea. Clinical data, including patient characteristics, surgical factors, and endoscopic findings, were analyzed. Patients were classified into an EBD-only group and an additional-intervention group (stent insertion or surgery). Univariate and multivariable logistic regression analyses were performed to identify predictors of EBD refractoriness.
RESULTS: Of the 56 patients, 45 (80.3%) achieved symptom improvement with EBD alone, whereas 11 (19.6%) required additional interventions. Diabetes mellitus and failure of scope passage were more frequent in patients who required additional interventions compared with those treated with EBD alone. Multivariable analysis indicated that only failure of scope passage remained an independent predictor (odds ratio, 16.81; 95% confidence interval, 1.61-411.44; p = 0.030). There was one procedure-related complication, aspiration pneumonia, which improved with conservative treatment.
CONCLUSIONS: EBD is an effective and safe first-line treatment for anastomotic strictures after distal gastrectomy. Failure of scope passage through the anastomosis is a simple yet reliable predictor of EBD refractoriness.